Drawing on oral evidence, patient testimony and Freedom of Information responses from 137 NHS Trusts and Health Boards, the inquiry examined how services could better meet the needs of the 3.5 million people living with the condition in the UK.
The inquiry identified systemic issues in access, quality and safety, with delays to diagnosis contributing to avoidable disability and premature death. It found variation across the country in scanner provision, waiting times and oversight of radiation safety standards.
Recommendations included a national review of waiting times, the inclusion of DXA in the specification for Community Diagnostic Centres, and an urgent investigation into quality and safety by the relevant regulatory bodies.
Read the full APPG report here.
The APPG held an oral evidence session on DXA services in May 2023. You can watch the recording on YouTube. Minutes are available on request.
